Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Non-invasive Evaluation Of Anthracycline-induced Cardiotoxicity In Man.

R. Lahtinen, M. Uusitupa, J. Kuikka, E. Länsimies
Published 1982 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Measurements of radionuclide first-pass left ventricular ejection fraction (LVEFrn) were carried out in 37 patients receiving doxorubicin and/or daunorubicin treatment for their malignant disease. The validity of the systolic time intervals (STI) and echocardiography (ECHO) in the detection of left ventricular dysfunction was evaluated using LVEFrn as reference method. LVEFrn showed a significant decrease in left ventricular function with cumulative anthracycline doses inpatients with and without previous clinical evidence of cardiovascular disease. A multiple regression analysis showed that the impairment in LVEFrn was significantly correlated with the cumulative anthracycline dose, patient's age and previous cardiovascular disease. In five patients (one without previous cardiac disease, one with coronary artery disease, three with hypertension) the drug had to be withdrawn due to signs or symptoms of cardiac dysfunction. The sensitivity and the specificity of STI and ECHO in the detection of left ventricular dysfunction remained rather low as compared with the results by LVEFrn.
This paper references
Quantitative radiocardiographic evaluation of cardiac dynamics in man at rest and during exercise.
J. Kuikka (1979)
Non-invasive measurement of left ventricular function in coronary artery disease. Comparison of first pass radionuclide ventriculography, M-mode echocardiography, and systolic time intervals.
F. Basilico (1981)
[Abnormal left-ventricular contraction and filling in patients receiving adriamycin for solid tumours (author's transl)].
E. Stein (1978)
Anthracycline cardiotoxicity: Clinical and pathologic outcomes assessed by radionuclide ejection fraction
J. Ritchie (1980)
Adriamycin cardiomyopathy—risk factors
R. A. Minow (1977)
Serial studies of cardiac function in patients receiving adriamycin.
I. C. Henderson (1978)
Time- and Dose‐Dependent Changes in Ejection Fraction After Anthracycline Therapy
K. A. Narahara (1979)
Echocardiographic evaluation of adriamycin cardiotoxicity in children.
A. Ramos (1976)
Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
J. Alexander (1979)
Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.
S. Al-Ismail (1979)
Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy.
J. Mason (1978)
Systolic Time Intervals in Heart Failure in Man
A. Weissler (1968)
Early anthracycline cardiotoxicity.
M. Bristow (1978)
Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements
D. Sahn (1978)
Anthracycline cardiomyopathy monitored by morphologic changes.
M. Billingham (1978)
Adriamycin cardiotoxicity in man.
J. Rinehart (1974)
Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity
A. Weiss (1977)
Bedside technics for the evaluation of ventricular function in man.
A. Weissler (1969)
A clinicopathologic analysis of adriamycin cardiotoxicity
E. Lefrak (1973)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar